Amylyx Pharmaceuticals, Inc.盘中异动急速下跌5.26%报3.60美元

自选股智能写手03-12

北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.26%。截至发稿，该股报3.60美元/股，成交量60.454万股，换手率0.89%，振幅2.24%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率5.23倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2418537494?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-12 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2418537494","market":"us","top_or_hot":-1,"title":"Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.26%。截至发稿，该股报3.60美元/股，成交量60.454万股，换手率0.89%，振幅2.24%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率5.23倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-12 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.26%。截至发稿，该股报3.60美元/股，成交量60.454万股，换手率0.89%，振幅2.24%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率5.23倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMLX","symbol_name":"Amylyx Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","article_id":"2418537494","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221321187e782f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2418537494","pubTimestamp":1710250331,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.26%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm  Plc涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为150.20%、127.39%、27.47%，振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited，振幅分别为34.35%、13.07%、12.26%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals, Inc.","BK4007":"制药"},"translate_title":"Amylyx Pharmaceuticals, Inc. plunged 5.26 percent to $3.60 in intraday activity","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMLX":1},"content_text":"北京时间2024年03月12日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价快速下跌5.26%。截至发稿，该股报3.60美元/股，成交量60.454万股，换手率0.89%，振幅2.24%。最近的财报数据显示，该股实现营业收入3.81亿美元，净利润49.27百万美元，每股收益0.73美元，毛利3.54亿美元，市盈率5.23倍。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，62%的券商给予持有建议，无券商给予卖出建议。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Regulus Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)、Tc Biopharm (Holdings) Plc涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm (Holdings) Plc较为活跃，换手率分别为150.20%、127.39%、27.47%，振幅较大的相关个股有Regulus Therapeutics Inc.、Scorpius Holdings, Inc.、Aslan Pharmaceuticals Limited，振幅分别为34.35%、13.07%、12.26%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。公司的唯一业务部门是研究和开发神经退行性疾病的治疗方法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2418537494"}

Amylyx Pharmaceuticals, Inc.盘中异动 急速下跌5.26%报3.60美元

精彩评论

Amylyx Pharmaceuticals, Inc.盘中异动急速下跌5.26%报3.60美元